Factors associated with COVID-19 vaccination in young children.

OBJECTIVE: To examine factors associated with COVID-19 vaccination (time to vaccination and vaccination status) among healthy young children participating in primary healthcare. METHODS: A cohort study was conducted between November 2021 and September 2022 through the TARGet Kids! primary care research network in Toronto, Canada. Sociodemographic information, child and parent health characteristics, parental vaccine beliefs and child COVID-19 vaccine uptake were collected through parent-reported questionnaires. The primary outcome was time to child COVID-19 vaccination, measured as the time between vaccine availability date and parent-reported child COVID-19 vaccination date. Interval-censored proportional hazard models were used. RESULTS: A total of 267 children age 0 to 13 years were included. The mean child age was 7.6 years, 52.8% (n = 141) were male, 66.5% (n = 141) had mothers of European ethnicity (with missingness), and 68.2% (n = 182) of the children were vaccinated. All parents of vaccinated children had received the COVID-19 vaccination themselves. The rate of vaccination for children was 2% higher with each one-month increase in child age (adjusted HR = 1.02, 95%CI = 1.01-1.03, p < 0.001). Compared to children whose parents had uncertain beliefs, those whose parents had positive beliefs about the importance and safety of COVID-19 vaccination for their children had higher rates of vaccination (adjusted HR = 8.29, 95%CI = 4.25-16.17, p < 0.001; adjusted HR = 5.09, 95%CI = 3.17-8.17, p < 0.001). CONCLUSION: Older child age, parental COVID-19 vaccination, and positive parental beliefs about COVID-19 vaccination were statistically significantly associated with COVID-19 vaccination among healthy young children. Our findings may help to inform policies, practices, and research which aim to strengthen parental vaccine confidence and promote child COVID-19 vaccination.

RéSUMé: OBJECTIF: Examiner les facteurs associés à la vaccination contre la COVID-19 (délai de vaccination et statut vaccinal) chez de jeunes enfants en bonne santé recevant des soins de santé primaires. MéTHODE: Une étude de cohorte a été menée entre novembre 2021 et septembre 2022 par le réseau de recherche en soins primaires TARGet Kids! à Toronto, au Canada. Des données sur le profil sociodémographique, les caractéristiques de santé des enfants et des parents, les convictions parentales à l'égard de la vaccination et la vaccination des enfants contre la COVID-19 ont été recueillies au moyen de questionnaires remplis par les parents. Le résultat principal était le délai de vaccination des enfants contre la COVID-19, mesuré comme étant le temps écoulé entre la date de disponibilité d'un vaccin et la date de vaccination de l'enfant contre la COVID-19 déclarée par le parent. Des modèles de risques proportionnels censurés par intervalle ont été utilisés. RéSULTATS: En tout, 267 enfants de 0 à 13 ans ont été inclus. Ils avaient 7,6 ans en moyenne, 52,8% (n = 141) étaient des garçons, 66,5% (n = 141) avaient une mère d'origine ethnique européenne (avec des données manquantes), et 68,2% (n = 182) étaient vaccinés. Tous les parents des enfants vaccinés étaient eux-mêmes vaccinés contre la COVID-19. Le taux de vaccination des enfants augmentait de 2 % pour chaque mois d'augmentation de l'âge des enfants (rapport de risques instantanés [RRI] ajusté = 1,02, intervalle de confiance [IC] de 95% = 1,01­1,03, p < 0,001). Comparativement aux enfants dont les parents étaient incertains dans leurs convictions, ceux dont les parents croyaient en l'importance et en l'innocuité de la vaccination contre la COVID-19 pour leurs enfants avaient des taux de vaccination plus élevés (RRI ajusté = 8,29, IC de 95% = 4,25­16,17, p < 0,001; RRI ajusté = 5,09, IC de 95% = 3,17­8,17, p < 0,001). CONCLUSION: L'âge plus avancé des enfants, la vaccination parentale contre la COVID-19 et les convictions parentales positives à l'égard de la vaccination contre la COVID-19 présentaient une corrélation significative avec la vaccination contre la COVID-19 chez les jeunes enfants en bonne santé. Nos constats pourraient contribuer à éclairer les politiques, les pratiques et la recherche visant à renforcer la confiance parentale en la vaccination et à promouvoir la vaccination des enfants contre la COVID-19.

Protocol for a pilot randomised controlled trial evaluating feasibility and acceptability of cognitive remediation group therapy compared with mutual aid group therapy for people ageing with HIV-associated neurocognitive disorder (HAND) in Toronto, Canada.

INTRODUCTION: HIV-associated neurocognitive disorder (HAND) may affect 30%-50% of people ageing with HIV. HAND may increase stress and anxiety, and impede coping. Psychosocial group therapy may ameliorate HAND's symptoms, yet the ideal intervention is unclear. This protocol outlines a pilot randomised controlled trial (RCT)-designed using community-based participatory research-to pilot cognitive remediation group therapy (CRGT) against an active comparator. METHODS AND ANALYSIS: This is a pilot, parallel design, two-arm RCT that will recruit participants diagnosed with the mild neurocognitive disorder form of HAND from a neurobehavioural research unit at a tertiary care hospital in Toronto, Canada. Eligibility criteria include age ≥40 years, known HIV status for 5+ years, English fluency, able to consent and able to attend 8 weeks of group therapy. Eligible participants will be randomised to one of two treatment arms, each consisting of eight-session group interventions delivered once weekly at 3 hours per session. Arm 1 (novel) is CRGT, combining mindfulness-based stress reduction with brain training activities. Arm 2 (active control) is mutual aid group therapy. The primary outcomes are feasibility, measured by proportions of recruitment and completion, and acceptability, determined by a satisfaction questionnaire. The secondary outcome is intervention fidelity, where content analysis will be used to assess facilitator session reports. A between-group analysis will be conducted on exploratory outcomes of stress, anxiety, coping and use of intervention activities that will be collected at three time points. ETHICS AND DISSEMINATION: Ethical approval was obtained from the Research Ethics Boards of St. Michael's Hospital and the University of Toronto. Findings will be disseminated through peer-reviewed publications, conference presentations and community reporting. This study could provide insight into design (eg, recruitment, measures) and intervention considerations (eg, structure, content) for a larger trial to lessen the burden of cognitive decline among people ageing with HIV. TRIAL REGISTRATION NUMBER: NCT03483740; Pre-results.